With around 10 million obese adults in the UK, once the drugs become cheaper than GBP 95 per month, it becomes beneficial for the UK government to buy GLP-1 drugs and make them available for free to eligible patients
Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously
Recognized as a bolus insulin, Humalog achieves high insulin levels rapidly, mirroring the release of endogenous insulin from the pancreas following meals, and maintains its action for approximately five hours
Clinical trial participation represents the only official access pathway, with limited Canadian trial sites
Not just nausea Another side effect of GLP-1 drugs is a decrease in thirst, which could be dangerous for people who are already losing lots of fluids from side effects like vomiting and diarrhea
: 73% Blue Waterlock - , , , 5 ,